The transcriptional coactivators p/CIP and SRC-1 control insulin resistance through IRS1 in obesity models

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Wang, Zhiyong ^a   Shah, O Jameel ^a,b   Hunter, Tony ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b Albany Molecular Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PROTEIN KINASE B; PROTEIN P160; S6 KINASE; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CELL LINEAGE; CONTROLLED STUDY; FOOD INTAKE; GENE DELETION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPID DIET; MALE; MOUSE; MUSCLE CELL; NONHUMAN; OBESITY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GLUCOSE TOLERANCE TEST; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; NIH 3T3 CELLS; NUCLEAR RECEPTOR COACTIVATOR 1; NUCLEAR RECEPTOR COACTIVATOR 3; OBESITY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

MUS;

EID: 84864464496     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036961     Document Type: Article

References (28)

1. Sonoda J, Pei L, Evans RM, ((2008)) Nuclear receptors: decoding metabolic disease. FEBS Lett 582:: 2--9.
2. Lonard DM, O'Malley BW, ((2007)) Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol Cell 27:: 691--700.
3. Rosenfeld MG, Lunyak VV, Glass CK, ((2006)) Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:: 1405--1428.
4. Evans RM, Barish GD, Wang YX, ((2004)) PPARs and the complex journey to obesity. Nat Med 10:: 355--361.
5. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, et al. ((1999)) PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4:: 585--595.
6. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, et al. ((1999)) PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:: 597--609.
7. Miles PD, Barak Y, He W, Evans RM, Olefsky JM, ((2000)) Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest 105:: 287--292.
8. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, et al. ((1999)) PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:: 611--617.
9. Wang Z, Rose DW, Hermanson O, Liu F, Herman T, et al. ((2000)) Regulation of somatic growth by the p160 coactivator p/CIP. Proc Natl Acad Sci U S A 97:: 13549--13554.
10. Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, et al. ((2000)) The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci U S A 97:: 6379--6384.
11. Picard F, Gehin M, Annicotte J, Rocchi S, Champy MF, et al. ((2002)) SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111:: 931--941.
12. Qi C, Zhu Y, Pan J, Yeldandi AV, Rao MS, et al. ((1999)) Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor alpha-regulated gene expression. Proc Natl Acad Sci U S A 96:: 1585--1590.
13. Wang Z, Qi C, Krones A, Woodring P, Zhu X, et al. ((2006)) Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance. Cell Metab 3:: 111--122.
14. Trujillo ME, Scherer PE, ((2005)) Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257:: 167--175.
15. Kadowaki T, Yamauchi T, ((2005)) Adiponectin and adiponectin receptors. Endocr Rev 26:: 439--451.
16. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. ((2002)) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Med. 8:: 1288--95.
17. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, et al. ((2003)) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:: 762--769.
18. Hardie DG, ((2008)) AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 32 Suppl 4: S7--12.
19. Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, et al. ((2009)) Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 41:: 1110--1115.
20. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B 3rd, et al ((1994)) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:: 186--190.
21. Nandi A, Kitamura Y, Kahn CR, Accili D, ((2004)) Mouse models of insulin resistance. Physiol Rev 84:: 623--647.
22. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, et al. ((1994)) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:: 182--186.
23. Terauchi Y, Iwamoto K, Tamemoto H, Komeda K, Ishii C, et al. ((1997)) Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J Clin Invest 99:: 861--866.
24. Coste A, Louet JF, Lagouge M, Lerin C, Antal MC, et al. ((2008)) The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}. Proc Natl Acad Sci U S A 105:: 17187--17192.
25. Hotamisligil GS, Erbay E, ((2008)) Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 8:: 923--934.
26. Qatanani M, Lazar MA, ((2007)) Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 21:: 1443--1455.
27. Yamauchi T, Kadowaki T, ((2008)) Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond) 32 Suppl 7: S13--18.
28. Waki H, Park KW, Mitro N, Pei L, Damoiseaux R, et al. ((2007)) The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. Cell Metab (5):: 357--70.